W E D N E S D A Y , O C T O B E R 3 R D , 2 0 1 2p R E l i m i N A R Y p R O G R A m

Conference Highlights Get ready for the Russian Market through key sessions not to be missed:

Develop a pro-active market entry strategy to grow your business in the Russian dynamic pharma environment!

Overview

In the past years, the global pharmaceutical industry has been experiencing a shift in its development: a geographic swing away from the major mature markets, to a set of new dynamics in “pharmerging” countries.

The Russian pharmaceutical market is one of these most dynamic and rapidly growing markets. Presently, its healthcare system is undergoing major changes bringing substantial challenges and opportunities for multinational pharmaceutical companies. Understanding the new legislation and the direction of the country’s pharmaceutical industry is therefore essential for the success in Russia.

OctOber 3rd, 2012Cité Internationale Universitaire of Paris, France

A 2012 Satellite Event

  Analyze the market dynamics and development perspectives. Understand the potential value of the Russian Market

  Get a clear appraisal of what the Healthcare reforms will look like

  Fuel sustainable development by M&A and Strategic Alliances

  Analyse the development potential for Generics & Biosimilars and build dynamic strategies to grow your business

  Understand the current challenges to reach the GMP standards and requirements

  Discover the new challenges for the distribution sector

  Gain a practical approach to clinical trials in different nosologies

1st editiOn

Pre l iminar y Program

W E D N E S D A Y , O C T O B E R 3 R D , 2 0 1 2p R E l i m i N A R Y p R O G R A m

360° REGulATORY REviEW

OvERviEW

STRATEGiC AlliANCES

Anna HArringtOn-MOrOzOvA, Scientific & Regulatory Director, regem consulting Ltd (UK) elena gAnkinA, Scientific & Regulatory Director, bMS (RU)

benjamin MunbLit, Director of the Analysis and Consultancy Department, comcon-Pharma (RU)

barbara vAn WiSSen, Director coordination, Emerging countries, Servier (FR) christoph gLAetzer, Vice President, Market Access - Asia Pacific, Janssen (SG) iMS representative Name To be confirmed (FR)

nikita MinAev, Director of Business Development, geropharm (RU)

08:30 - 09:00 Registration

10:30 - 11:00 Networking break

01:00 - 02:30 lunch break

11:00 - 11:30 Overview of the Russian pharmaceutical market: characteristics, major trends and forecasts

09:00 - 10:30 Future value of emerging BRiCS markets

11:30 - 12:15 New regulatory environment: challenges and opportunities

12:15 - 01:00 Strategic alliances: a key factor for a competitive market

Focus on the Russian pharmaceutical market

Russian and global pharmaceutical market Strategy of development and investment opportunities Introduction to the “Pharma 2020” Program

Understand the potential value of emerging BRICS markets Learn how to build dynamic strategies that will grow your business

Gain insight from leading pharma experts on emerging markets

Licensing and IP protection Regulatory requirements for drug approval, registration and control

Trends in the pricing and reimbursement system Reformation of drugs procurement performed by the state Antitrust regulation

International partnering: a tool for efficient business strategies’ implementation

Joint Venturing: partnering with domestic manufacturers Knowledge transfer and investing into Human Resources Local partnering: prospects of biopharmaceutical clusters development

Strategic investment into Biotech

plENARYSESSiON

W E D N E S D A Y , O C T O B E R 3 R D , 2 0 1 2p R E l i m i N A R Y p R O G R A m

Russian Market Access Conference is organized in conjunction with:

For more information about Innovation Days, please visit the event website: www.lifescience-outlook.com

DiSTRiBuTiON

CliNiCAl TRiAlS

03:15 - 04:00 New challenges for distribution sector

04:00 - 04:45 Overview of essential information for clinical trials in Russia

New challenges for distribution

Conducting clinical trials in Russia in practice

Distribution development models Creating a mutually beneficial relationship with distributors Partnering with pharmacy chains to make the difference to your distribution strategy

Additional revenue sources and costs optimization

Overview of the clinical trials environment Clinical trials procedures Outsourcing opportunities

Speakers invitedTo be confirmed

eugene SeLivrA, CEO, global clinical trials, LLc (USA) vladimir krechikov, Director of Business development, cromos Pharma (RU)

04:45 - 06:00 Networking Reception cOnference LAnguAge:

engLiSH

KEY GROWTH DRivERS

02:30 - 03:15 Ensuring a sustainable development for your business: what are the next steps?

Learn what will ensure sector growth in the coming years? Securing a market share: Generics, Biosimilars, OTC – what will be the key playing field in pharma over the next 10-15 years?

Creating the right mix for a competitive product portfolio

nickolay deMidOv, CEO, Pharmexpert (RU)

OctOber 3rd, 2012Cité Internationale Universitaire of Paris, France

A 2012 Satellite Event

universal medica Group106, Bureaux de la Colline92213 Saint-Cloud+33 (0)1 41 12 27 77

Nina Doumbadze, Project Managernina.doumbadze@universalmedica.com

Laura Halley, Business Developerlaura.halley@universalmedica.com

www.lifescience-outlook.com/russianmarketaccess

find Out MOre...

cOntActS